Literature DB >> 9316488

N-acetylcysteine does not protect against type II cell injury after prolonged exposure to hyperoxia in rats.

R J van Klaveren1, D Dinsdale, J L Pype, M Demedts, B Nemery.   

Abstract

Although the antioxidant properties of N-acetylcysteine (NAC) in vitro are widely accepted, the efficacy of NAC in the prevention of O2 toxicity in vivo is poorly documented. The aim of our study was to investigate the presumed protective effect of NAC on hyperoxic lung injury, focusing on gamma-glutamyltransferase (gamma-GT) activity and glutathione (GSH) levels in lung tissue, epithelial lining fluid (ELF), and isolated rat type II cells immediately after their isolation and 48 h later when kept in culture in normoxia. Thirty-four male Wistar rats were divided in three groups (n = 10-14) and were exposed to air or to 60 or 85% O2 for 7 days. One-half of the rats in each group received 200 mg/kg NAC intraperitoneally one time per day from 3 days before exposure until the end of the experiment, and the other one-half received the vehicle. In the 85% O2-exposed animals, NAC led to more respiratory distress and weight loss. NAC did not prevent the rise in bronchoalveolar lavage lactate dehydrogenase and alkaline phosphatase, but it did prevent the rise in calculated ELF volume. NAC decreased GSH levels (1.4-fold) and gamma-GT activity (1.8-fold) in the air-exposed type II cells. In the 60% O2-exposed group, no effects of NAC were seen (except for a decrease in gamma-GT mRNA expression), but, in the 85% O2-exposed group, NAC gave rise to higher GSH (2.6-fold) and higher gamma-GT activity (2.9-fold) in the ELF and lower GSH (6.9-fold) and higher gamma-GT activity (3.6-fold) in the type II cells. Even in culture, GSH levels remained 1.5-fold lower than in the cells from the air-exposed animals and 2-fold lower than in the cells from the 85% O2-exposed animals. There was increased DNA damage (as assessed by thymidine incorporation) and apoptosis after hyperoxia, especially after 60% O2, and this effect was amplified after NAC treatment. Although protective at the endothelial side, NAC treatment led to adverse effects at the epithelial side, despite, or probably because of, restoration of the ELF GSH levels in the presence of high O2 levels. Because NAC is rapidly metabolized to cysteine, it is plausible that the effects of NAC are manifested through the toxic effects of cysteine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316488     DOI: 10.1152/ajplung.1997.273.3.L548

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

Review 1.  Therapies that enhance pulmonary vascular NO-signaling in the neonate.

Authors:  Julie Dillard; Marta Perez; Bernadette Chen
Journal:  Nitric Oxide       Date:  2019-12-20       Impact factor: 4.427

2.  Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes.

Authors:  Sukhdev Singh Kamboj; Kanwaljit Chopra; Rajat Sandhir
Journal:  Metab Brain Dis       Date:  2008-09-19       Impact factor: 3.584

3.  Adiponectin protects against hyperoxic lung injury and vascular leak.

Authors:  Sean M Sliman; Rishi B Patel; Jason P Cruff; Sainath R Kotha; Christie A Newland; Carrie A Schrader; Shariq I Sherwani; Travis O Gurney; Ulysses J Magalang; Narasimham L Parinandi
Journal:  Cell Biochem Biophys       Date:  2013-11       Impact factor: 2.194

4.  Mouse lung development and NOX1 induction during hyperoxia are developmentally regulated and mitochondrial ROS dependent.

Authors:  Ankur Datta; Gina A Kim; Joann M Taylor; Sylvia F Gugino; Kathryn N Farrow; Paul T Schumacker; Sara K Berkelhamer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-06-19       Impact factor: 5.464

Review 5.  Developmental regulation of antioxidant enzymes and their impact on neonatal lung disease.

Authors:  Sara K Berkelhamer; Kathryn N Farrow
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

6.  Mechanism and Therapies of Oxidative Stress-Mediated Cell Death in Ischemia Reperfusion Injury.

Authors:  Haobo Li; Zhengyuan Xia; Yanfang Chen; Dake Qi; Hong Zheng
Journal:  Oxid Med Cell Longev       Date:  2018-06-24       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.